Jynarque - bulk
Ended Awarded Last action
- Contract number
- 36C26025F0007
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $637,703
Award facts
- Contract value 100% obligated
- $637,703.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Belle Isle, FL 32809, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$92,327 | |
| Funding Only Action | $277,000 | |
| Original award | $453,031 |
About this award
Otsuka America Pharmaceutical Inc. was awarded a delivery order valued at $637,703.39 by Veterans Integrated Service Network 20, effective October 1, 2024, with completion targeted for September 30, 2025. This firm fixed-price contract, which includes a 2025 price increase adjustment, procures Jynarque (tolvaptan) in bulk—a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations. The delivery order does not utilize a set-aside designation and falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with performance taking place in Belle Isle, Florida.
This award represents a task order issued against Otsuka America Pharmaceutical Inc.'s existing Blanket Purchase Agreement with the VA's National Acquisition Center, valued at $83.3 million with a completion date of March 26, 2026. The BPA enables VA Integrated Service Networks across the country to efficiently procure Jynarque through streamlined ordering processes, supporting the Veterans Health Administration's mission to provide specialized pharmaceutical treatments to veterans. Otsuka America Pharmaceutical Inc. maintains an established supplier relationship with the VA through multiple indefinite delivery vehicles, including a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products, demonstrating substantial capability to support federal healthcare systems.
Quick answers
Who was awarded contract 36C26025F0007?
36C26025F0007 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C26025F0007 worth?
The government has obligated $637,703 on 36C26025F0007.
Is contract 36C26025F0007 an order under another contract?
Yes. 36C26025F0007 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0007 competed?
The extent of competition for 36C26025F0007 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award